prof. dr. H.M. (Helena) Verkooijen
Full Professor
- Clinical Trial Office
- Julius Center Research Program Cancer
Contact
Biography
Professor of Evaluation of Image-Guided Treatment, dedicated to improve the life of people with cancer. Committed to full integration of clinical research in routine patient care in order to facilitate undelayed evidence-based implementation of innovations in oncology.
Leader (PI) of several international (H2020) research consortia and academic industrial partnership, head of clinical research office and investigator in a range of (international) scientific studies. Strong background in teaching and development of educational modules at graduate and postgraduate level. Large international academic experience in Europe and Asia. Experienced speaker, moderator, and panel member.
Within the Division of Imaging and Cancer of the UMC Utrecht, I am responsible for clinical evaluation of innovative cancer treatments, and for evaluating to what extent theoretical benefits of these innovations translate into real benefits for patients. I lead a team of post-doc researchers, PhD students, and (medical) graduate students. I also lead the division’s clinical research office, which is responsible for trial support, data management, IT solutions, quality control and medico-ethical advise (supporting 200 academic researchers).
I lead two international consortia (one H2020 European, one transatlantic) and collaborate closely with (international) academic and industry partners. I am regularly invited as speaker at international conferences, educational sessions and consortium meetings, and as panelist at meetings/debates of professional organizations. I serve as a member in several scientific advisory boards and expert committees.
I am Strategic Advisor for 'NTvG Gezonde Zorg', a campaign of the Dutch Journal of Medicine (Nederlands Tijdschrift voor Geneeskunde). This campaign contributes to ensuring sustainability and affordability of health care in the Netherlands by exposing the harms of medicalisation (overdiagnosis and overtreatment) and explicitly demonstrating the power of (primary) prevention.
Side Activities
- Strategic Advisor 'NTvG Gezonde Zorg'
- Board Member Dutch Breast Cancer Research Group (Borstkanker Onderzoek Groep, BOOG)
- Member Scientific Advisory Board Dutch Expert Centre for Screening
- Board Member J.M. Fentener van Vlissingen Fonds
- Member Scientific Advisory Board Dutch Prospective Colorectal Cancer Cohort (PLCRC)
- Member Expert Committee Value-Based Health Care Breast Cancer (NFU)
Research Output (269)
The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study
Hoendervangers S, Sparreboom C L, Intven M P W, Lange J F, Verkooijen H M, Doornebosch P G, van Grevenstein W M U sep 2020, In: European Journal of Surgical Oncology. 46 , p. 1605-1612
Radiotherapie op geleide van het actuele MRI-beeld Een innovatie voor patiënten met een maligniteit in de bovenbuik
Daamen Lois A., Heerkens Hanne D., Molenaar I. Q., Verkooijen H. M., Meijer Gert J., Intven Martijn P.W. aug 2020, In: Nederlands Tijdschrift voor Geneeskunde. 164
The trials within cohorts design facilitated efficient patient enrollment and generalizability in oncology setting
Couwenberg Alice M, Burbach Johannes P M, May Anne, Berbee Maaike, Intven Martijn P W, Verkooijen Helena M 1 apr 2020, In: Journal of Clinical Epidemiology. 120 , p. 33-39 7 p.
Tumor Response After Neoadjuvant Magnetic Resonance Guided Single Ablative Dose Partial Breast Irradiation
Vasmel Jeanine E, Charaghvandi Ramona K, Houweling Antonetta C, Philippens Marielle EP, van Asselen Bram, Vreuls Celien PH, van Diest Paul J, van Leeuwen Am Gijs, van Gorp Joost, Witkamp Arjen J, Koelemij Ron, Doeksen Annemiek, Sier Maartje F, van Dalen Thijs, van der Wall Elsken, van Dam Iris, Veldhuis Wouter B, Kirby Anna M, Verkooijen Helena M, van den Bongard HJG Desiree 15 mrt 2020, In: International Journal of Radiation Oncology Biology Physics. 106 , p. 821-829 9 p.
Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment:a prospective cohort study
Pielkenrood B J, van Urk P R, van der Velden J M, Kasperts N, Verhoeff J J C, Bol G H, Verkooijen H M, Verlaan J J mrt 2020, In: Acta Oncologica. 59 , p. 291-297 7 p.
Patient-Reported Work Ability During the First Two Years After Rectal Cancer Diagnosis
Couwenberg Alice M, Intven Martijn P W, Gregorowitsch Madelijn Leoniek, Haaring Cees, van Grevenstein Wilhelmina, Verkooijen Helena Marieke 3 feb 2020, In: Diseases of the Colon and Rectum. 63 , p. 578-587 10 p.
Deep learning for automatic calcium scoring in CT:Validation using multiple cardiac CT and chest CT protocols
van Velzen Sanne G.M., Lessmann Nikolas, Velthuis Birgitta K., Bank Ingrid E.M., van den Bongard Desiree H.J.G., Leiner Tim, de Jong Pim A., Veldhuis Wouter B., Correa Adolfo, Terry James G., Carr John Jeffrey, Viergever Max A., Verkooijen Helena M., Išgum Ivana 1 jan 2020, In: Radiology. 295 , p. 66-79 14 p.
Stereotactic 9-gauge vacuum-assisted breast biopsy, how many specimens are needed?
den Dekker Bianca M, van Diest Paul J, de Waard Stephanie N, Verkooijen Helena M, Pijnappel Ruud M nov 2019, In: European Journal of Radiology. 120
Introducing the CONsolidated Standards of Reporting Trials (CONSORT) statement for randomised controlled trials (RCTs) using cohorts and routinely collected health data
Juszczak Edmund, Kwakkenbos Linda, McCall Stephen, Imran Mahrukh, Hemkens Lars G., Zwarenstein Merrick, Frobert Ole, Relton Clare, Sampson Margaret, Thabane Chair Lehana, Benchimol Eric I., Campbell Marion K., Torgerson David J., Erlinge David, Rice Danielle B., Langan Sinead, Mc Cord Kimberly A., van Staa Tjeerd P., Moher David, Verkooijen Helena M., Uher Rudolf, Worron-Sauve Maureen B., Boutron Isabelle, Ravaud Philippe, Thombs Brett D., Gale Chris okt 2019, 20
The Trials within Cohorts design faced methodological advantages and disadvantages in the exercise oncology setting
Gal Roxanne, Monninkhof Evelyn M, van Gils Carla H, Groenwold Rolf H H, van den Bongard Desirée H J G, Peeters Petra H M, Verkooijen Helena M, May Anne M sep 2019, In: Journal of Clinical Epidemiology. 113 , p. 137-146 10 p.